Detalhe da pesquisa
1.
Feasibility of allogeneic hematopoietic stem cell transplantation in advanced age.
Ann Hematol
; 103(2): 583-591, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37923805
2.
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
N Engl J Med
; 382(9): 822-834, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101664
3.
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 58(5): 498-505, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721042
4.
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation.
Blood Adv
; 6(22): 5898-5907, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977079
5.
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.
Blood Adv
; 6(5): 1525-1535, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34507354
6.
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant.
Bone Marrow Transplant
; 56(11): 2749-2754, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253878
7.
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.
Blood Adv
; 5(17): 3397-3406, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34432870
8.
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy.
Transplant Cell Ther
; 27(9): 771.e1-771.e10, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033977
9.
How I treat adverse effects of CAR-T cell therapy.
ESMO Open
; 4(Suppl 4): e000746, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839196
10.
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice.
Front Immunol
; 11: 888, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477359
11.
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
Blood Adv
; 4(4): 676-686, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32084260
12.
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.
J Palliat Med
; 23(12): 1653-1657, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32216649
13.
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients.
Leuk Lymphoma
; 61(8): 1833-1841, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228298
14.
CAR T Cell Toxicity: Current Management and Future Directions.
Hemasphere
; 3(2): e186, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723825
15.
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 56(1): 289-292, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694543
16.
CAR T cells: The future is already present. / Células CAR T: el futuro ya es presente.
Med Clin (Barc)
; 152(7): 281-286, 2019 04 05.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-30392694
17.
Células CAR T: el futuro ya es presente / CAR T cells: The future is already present
Med. clín (Ed. impr.)
; 152(7): 281-286, abr. 2019. graf, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-183548